Humacyte

Humacyte

Humacyte

Humacyte uses proprietary technology to grow stable, offtheshelf human tissuereplacements such as vein grafts to predesigned clinical and commercial specifications..
Type
B2c
Raised
$302.8M
Follow us
Alexa global traffic share
Latest funding Show all
$74,999,980
Venture capital (Series C) - 2018
$18,000,000
Venture capital - 2017
California Institute for Regenerative Medicine
Team Size
1–10
Employees
$10,000,000 Venture capital
Cary, Morrisville, Apex, Holly Springs, Raleigh, Fuquay Varina , Triangle, Durham, Real Estate Blog

RTP's Humacyte gets $10M from California stem cell group

Xconomy

California Agency Awards Humacyte $9.9M for Blood Vessel Technology

Health Science Funding
$150,000,000 Venture capital (Series B)
Xconomy

Humacyte Lands $150M Series B for Phase 3 Study of Lab-Grown Veins

Health Science